Jing Song Wang
Chief Executive Officer bei HBM HOLDINGS LIMITED
Profil
Jing Song Wang is the Chairman and CEO of HBM Holdings Ltd.
He is also the CEO of Hbm Suzhou Co. Ltd.
and Hbm Guangzhou.
He is an Independent Director at Xinjiang Baihuacun Pharam Tech Co., Ltd., Silicon INSITE, Inc., and InSilico Medicine Cayman TopCo. He is an Independent Non-Executive Director at Frontage Holdings Corp.
Dr. Wang was the Head of Research and Development at Sanofi (China) Investment Co. Ltd.
from 2011 to 2015.
He holds a graduate degree from Jilin University and Xuzhou Medical University, and a doctorate from China Pharmaceutical University.
Dr. Wang founded HBM Holdings Ltd.
in 2016.
Aktive Positionen von Jing Song Wang
| Unternehmen | Position | Beginn |
|---|---|---|
| FRONTAGE HOLDINGS CORPORATION | Director/Board Member | - |
| HBM HOLDINGS LIMITED | Chief Executive Officer | 20.07.2016 |
| XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Director/Board Member | 17.09.2021 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Chief Executive Officer | - |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Director/Board Member | 01.08.2016 |
| Hbm Suzhou Co. Ltd. | Chief Executive Officer | - |
| Hbm Guangzhou | Chief Executive Officer | - |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Director/Board Member | 01.06.2023 |
Ehemalige bekannte Positionen von Jing Song Wang
| Unternehmen | Position | Ende |
|---|---|---|
| Sanofi (China) Investment Co. Ltd. | Corporate Officer/Principal | 01.12.2015 |
Ausbildung von Jing Song Wang
| Jilin University | Graduate Degree |
| China Pharmaceutical University | Doctorate Degree |
| Xuzhou Medical University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Commercial Services |
| FRONTAGE HOLDINGS CORPORATION | Health Technology |
| HBM HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Health Technology |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
| Sanofi (China) Investment Co. Ltd. | |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
| Hbm Suzhou Co. Ltd. | |
| Hbm Guangzhou |
